Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: Relevance to diabetic retinopathy

Diabetologia

Volumn 40, Issue 2, 1997, Pages 156-164

  Chibber, R ^a   Molinatti, P A ^a   Rosatto, N ^a   Lambourne, B ^a   Kohner, E M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Advanced glycation end products; AGE receptor; Diabetic retinopathy; Endothelial cells; Pericyte

Indexed keywords

ALBUMIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SURFACE; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; GLYCATION; ISOTOPE LABELING; NONHUMAN; PERICYTE; PRIORITY JOURNAL; RECEPTOR BINDING; RETINA CAPILLARY;

ALBUMINS; ANIMALS; CAPILLARIES; CATTLE; CELLS, CULTURED; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ENDOTHELIUM; GLYCOSYLATION END PRODUCTS, ADVANCED; RETINAL VESSELS;

EID: 0031019299     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050657     Document Type: Article

References (38)

1. Bucala R, Cerami A (1992) Advanced glycosylation: chemistry, biology and implications for diabetes and aging. Adv Pharmacol 23: 1-34
2. Makita Z, Radoff S, Rayfield EJ et al. (1991) Advanced glycosylation endproducts in patients with diabetic nephropathy. N Engl J Med 325: 836-842
3. Oimoni M, Maeda Y, Hata F, Ketamura Y, Matsumoto S, Hatanaka H, Baba S (1988) A study of the age-related acceleration of glycation of tissue protein in rats. J Gerontol 43: B98-B101
4. Monnier VM, Kohn RR, Cerami A (1984) Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81: 583-587
5. Brownlee M (1992) Glycation products and the pathogenesis of diabetic complications. Diabetes Care 15: 1835-1843
6. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H (1990) Advanced protein glycosylation induces selective transendothelial human monocyte chemotaxis and secretion of PDGF: a role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 87: 9010-9014
7. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium dependent vasodilation in experimental diabetes. J Clin Invest 87: 432-438
8. Crowley STM, Brownlee M, Edelstein JA, Satriano T, Mori P, Singhal P, Schlondorff D (1991) Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40: 540-547
9. Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ (1991) Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation endproducts is mediated by PDGF. Proc Natl Acad Sci USA 89: 2873-2877
10. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H (1989) Endothelial receptor binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170: 1387-1407
11. Vlassara H (1994) Recent progress on the biologic and clinical significance of advanced glycosylation end products. J Lab Clin Med 124: 19-30
12. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H (1991) Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J Exp Med 174: 931-939
13. Kirstein M, Aston C, Hintz R, Vlassara H (1992) Receptor-specific induction of insulin-like growth factor (IGF-1) in human monocytes by advanced glycosylation endproduct-modified proteins. J Clin Invest 90: 439-446
14. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R (1992) Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA 84: 12043-12047
15. Monnier VM, Elmets CA, Frank KE, Vishvanath V, Yamashita T (1986) Age-related normalization of the browning rate of collagen in diabetic subjects without retinopathy. J Clin Invest 78: 832-835
16. Davis MD (1993) Diabetic retinopathy - a clinical overview. Diabetes Care 15: 1844-1873
17. Chibber R, Molinatti PA, Wong JS, Mirlees D, Kohner EM (1994) The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes. Diabetes 43: 758-763
18. Nayak RC, Berman AB, George GL, Eisenbarth GS, King GL (1988) A monoclonal antibody 3G5-defined ganglioside antigen is expressed on the surface of microvascular pericytes. J Exp Med 167: 1003-1015
19. Bowman PD, Betz AC, Goldstein GW (1982) Primary cultures of microvascular cells from bovine retina. In Vitro 18: 626-632
20. Makita Z, Vlassara H, Cerami A, Bucala R (1992) Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem 267: 5133-5138
21. McConhey PJ, Dixon FJ (1980) Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol 70: 220-223
22. Laemmli VK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685
23. Kubawara T, Cogan DG (1963) Retinal vascular patterns VI. Mural cells of the retinal capillaries. Arch Ophthalmol 69: 492-502
24. Horiuchi S, Araki N, Morino Y (1993) Immunochemical approach to characterize advanced glycation end products of the Maillard reaction: evidence for the presence of a common structure. J Biol Chem 266: 7329-7332
25. Yamagishi S, Hsu C, Taniguchi M et al. (1995) Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy. Biochem Biophys Res Commun 213: 681-687
26. Tezuka M, Koyama N, Morisak N, Saito Y, Yoshida S, Araki N, Horiuchi S (1993) Angiogenic effect of advanced glycation end products of the Maillard reaction on cultured human umbilical cord vein endothelial cells. Biochem Biophys Res Commun 193: 674-680
27. Hogan M, Cerami A, Bucala R (1992) Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. J Clin Invest 90: 1110-1115
28. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissues and the biochemical basis of diabetic complications. N Engl J Med 318: 1316-1318
29. Vlassara H (1992) Receptor-mediated interactions of advanced glycosylation end products with cellular components within diabetic tissues. Diabetes 41: 52-56
30. Yang Z, Makita Z, Horii Y et al. (1991) Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins. J Exp Med 174: 515-524
31. Schmidt AM, Yan SD, Brett J, Mora R, Nowygrod R, Stern D (1993) Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 91: 2155-2168
32. Stitt W, Yong ML, Gardiner TA, Vlassara H (1996) Intracellular advanced glycation endproducts (AGEs) co-localize with AGE-receptors in the retinal vasculature of diabetic and AGE-infused rats. Diabetes [Suppl] 45: 15A (Abstract)
33. Schmidt AM, Yan SD, Stern DM (1996) The dark side of glucose. Nature Medicine 1: 1002-1004
34. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptor/binding proteins. J Biol Chem 269: 9889-9897
35. Schmidt AM, Hori O, Chen J, Brett J, Stern D (1995) AGE interaction with their endothelial receptor induces expression of VCAM-1: a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96: 1375-1403
36. Kohner EM (1993) Diabetic retinopathy. BMJ 307: 1195-1199
37. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M (1991) Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88: 11555-11558
38. Beisswenger PJ, Makita Z, Curphey TJ et al. (1995) Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44: 824-829